Nasdaq:US$13.33 (+0.13) | HKEX:HK$20.62 (+0.16) | AIM:£2.09 (+0.11)
搜索結果
上一篇文章   |   下一篇文章
公告及新聞稿, 腫瘤學 / 免疫學 | 2006-07-04

Chi-Med plans to broaden clinical trials of its leading oncology drug candidate